在患有喘的小学年龄儿童中使用干粉吸入器:系统性审查
Stephanie L Kuek1,2, Nicole X Wong3, Stuart Dalziel4,5,6
1Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Australia.
ERJ open research
|December 10, 2024
概括
大多数小学龄儿童可以在接受培训后使用干粉吸入器 (DPI). 临床评估是确定喘儿童的DPI适合性的关键,尽管需要对急性情况进行更多研究.
科学领域:
- 儿科肺病学 儿科肺病学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是儿童常见的慢性呼吸道疾病.
- 干粉吸入器 (DPI) 与带间隔器的计量剂量吸入器 (MDI) 相比,具有优势,包括便携性和环境效益.
- 小学年龄 (5-11岁) 儿童使用DPI的可用性需要进行具体的评估.
研究的目的:
- 评估有关小学龄儿童有效使用DPI的能力的证据.
- 在稳定和急性喘恶化情景中评估DPI技术的充分性.
- 为了比较DPI的有效性和可用性与传统的MDI与间隔器设备.
主要方法:
- 在Ovid MEDLINE,Embase和PubMed中进行了系统的文献搜索.
- 研究的选择是基于评估在5至11岁的患有喘或喘息的儿童中使用DPI.
- 数据综合涉及按设计和结果指标分组研究,包括峰值启发性流量,医生评估和比较疗效.
主要成果:
- 对38项研究的分析表明,大多数5至11岁的儿童可以通过适当的培训和支持掌握DPI技术.
- 医生评估和持续审查至关重要,因为一些年幼的孩子可能会遇到困难.
- 在急性喘恶化期间使用DPI的证据有限,需要进一步调查.
结论:
- 大多数小学龄儿童可以有效地使用DPI,但个体评估至关重要.
- 一致的正确使用和坚持是挑战,与带有间距装置的MDI相比.
- 需要进一步的研究,以充分理解DPI在这种年龄组的急性喘恶化期间的实用性.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.6K
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
794
相关概念视频
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237